β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
Open Access
- 1 April 2007
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 282 (15), 11329-11338
- https://doi.org/10.1074/jbc.m611526200
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- ERK MAP kinase in G1 cell cycle progression and cancerCancer Science, 2006
- Expression and Growth Dependency of the Insulin-Like Growth Factor I Receptor in Craniopharyngioma Cells: A Novel Therapeutic ApproachClinical Cancer Research, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- Real-time monitoring of ubiquitination in living cells by BRETNature Methods, 2004
- Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2Science, 2003
- The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK ActivationPublished by Elsevier BV ,2003
- IGF-1 receptor regulates lifespan and resistance to oxidative stress in miceNature, 2002
- Insulin and Insulin-like Growth Factor I Receptors Utilize Different G Protein Signaling ComponentsJournal of Biological Chemistry, 2001
- Domains of the Insulin-Like Growth Factor I Receptor Required for the Activation of Extracellular Signal-Regulated KinasesEndocrinology, 2000
- β-Arrestin: a Protein that Regulates β-adrenergic Receptor FunctionScience, 1990